Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Metabolically Fit CD19 CAR T-cell Therapy With CD34 Selection in Patients With CD19+ Relapsed/Refractory NHL, CLL/SLL
Apply
CD19 CAR T-Cell Therapy
Metabolically Fit CD19 CAR T-cell Therapy With CD34 Selection in Patients With CD19+ Relapsed/Refractory NHL, CLL/SLL
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step